THERMO FISHER SCIENTIFIC INC (TN8.DE) Stock Fundamental Analysis
Europe - FRA:TN8 - US8835561023 - Common Stock
494.75 EUR
+11.85 (+2.45%)
We assign a fundamental rating of 4 out of 10 to TN8. TN8 was compared to 18 industry peers in the Life Sciences Tools & Services industry. TN8 has an average financial health and profitability rating. TN8 is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
TN8 had positive earnings in the past year.
TN8 had a positive operating cash flow in the past year.
Each year in the past 5 years TN8 has been profitable.
In the past 5 years TN8 always reported a positive cash flow from operatings.
1.2 Ratios
TN8 has a Return On Assets of 6.38%. This is in the better half of the industry: TN8 outperforms 72.22% of its industry peers.
Looking at the Return On Equity, with a value of 12.88%, TN8 is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
TN8 has a Return On Invested Capital of 6.43%. This is comparable to the rest of the industry: TN8 outperforms 55.56% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for TN8 is in line with the industry average of 7.57%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.38% | ||
| ROE | 12.88% | ||
| ROIC | 6.43% |
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.8%
ROE(5y)15.76%
ROIC(3y)6.66%
ROIC(5y)7.62%
1.3 Margins
The Profit Margin of TN8 (15.02%) is better than 77.78% of its industry peers.
In the last couple of years the Profit Margin of TN8 has remained more or less at the same level.
TN8 has a better Operating Margin (18.40%) than 72.22% of its industry peers.
TN8's Operating Margin has improved in the last couple of years.
TN8 has a Gross Margin (41.43%) which is in line with its industry peers.
TN8's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.4% | ||
| PM (TTM) | 15.02% | ||
| GM | 41.43% |
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-6.24%
GM growth 5Y-1.42%
2. Health
2.1 Basic Checks
TN8 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for TN8 has been reduced compared to 1 year ago.
Compared to 5 years ago, TN8 has less shares outstanding
Compared to 1 year ago, TN8 has an improved debt to assets ratio.
2.2 Solvency
TN8 has a debt to FCF ratio of 5.84. This is a neutral value as TN8 would need 5.84 years to pay back of all of its debts.
The Debt to FCF ratio of TN8 (5.84) is better than 61.11% of its industry peers.
A Debt/Equity ratio of 0.62 indicates that TN8 is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.62, TN8 perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 5.84 | ||
| Altman-Z | N/A |
ROIC/WACC0.63
WACC10.18%
2.3 Liquidity
A Current Ratio of 1.50 indicates that TN8 should not have too much problems paying its short term obligations.
TN8 has a Current ratio (1.50) which is in line with its industry peers.
A Quick Ratio of 1.11 indicates that TN8 should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.11, TN8 is in line with its industry, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.11 |
3. Growth
3.1 Past
TN8 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.53%.
The Earnings Per Share has been growing by 12.12% on average over the past years. This is quite good.
Looking at the last year, TN8 shows a small growth in Revenue. The Revenue has grown by 3.22% in the last year.
The Revenue has been growing by 10.92% on average over the past years. This is quite good.
EPS 1Y (TTM)4.53%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%9.66%
Revenue 1Y (TTM)3.22%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%4.94%
3.2 Future
TN8 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.78% yearly.
The Revenue is expected to grow by 4.62% on average over the next years.
EPS Next Y3.97%
EPS Next 2Y6.16%
EPS Next 3Y7.56%
EPS Next 5Y9.78%
Revenue Next Year2.82%
Revenue Next 2Y3.82%
Revenue Next 3Y4.52%
Revenue Next 5Y4.62%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 25.38 indicates a quite expensive valuation of TN8.
TN8's Price/Earnings ratio is in line with the industry average.
TN8 is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.03, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 23.08, TN8 is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as TN8.
The average S&P500 Price/Forward Earnings ratio is at 22.27. TN8 is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.38 | ||
| Fwd PE | 23.08 |
4.2 Price Multiples
61.11% of the companies in the same industry are cheaper than TN8, based on the Enterprise Value to EBITDA ratio.
TN8's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.14 | ||
| EV/EBITDA | 22.62 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
TN8 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)6.39
PEG (5Y)2.1
EPS Next 2Y6.16%
EPS Next 3Y7.56%
5. Dividend
5.1 Amount
With a yearly dividend of 0.31%, TN8 is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.72, TN8 is paying slightly less dividend.
With a Dividend Yield of 0.31, TN8 pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.31% |
5.2 History
On average, the dividend of TN8 grows each year by 15.42%, which is quite nice.
Dividend Growth(5Y)15.42%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
9.48% of the earnings are spent on dividend by TN8. This is a low number and sustainable payout ratio.
The dividend of TN8 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP9.48%
EPS Next 2Y6.16%
EPS Next 3Y7.56%
FRA:TN8 (11/4/2025, 7:00:00 PM)
494.75
+11.85 (+2.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners91.65%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap186.82B
Revenue(TTM)43.74B
Net Income(TTM)6.57B
Analysts81.76
Price Target537.54 (8.65%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.31% |
Yearly Dividend1.32
Dividend Growth(5Y)15.42%
DP9.48%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.99%
Min EPS beat(2)1.61%
Max EPS beat(2)4.37%
EPS beat(4)3
Avg EPS beat(4)1.9%
Min EPS beat(4)-0.07%
Max EPS beat(4)4.37%
EPS beat(8)5
Avg EPS beat(8)2.24%
EPS beat(12)7
Avg EPS beat(12)1.19%
EPS beat(16)11
Avg EPS beat(16)4.2%
Revenue beat(2)2
Avg Revenue beat(2)0.79%
Min Revenue beat(2)0.62%
Max Revenue beat(2)0.95%
Revenue beat(4)4
Avg Revenue beat(4)0.47%
Min Revenue beat(4)0.04%
Max Revenue beat(4)0.95%
Revenue beat(8)6
Avg Revenue beat(8)0.12%
Revenue beat(12)7
Avg Revenue beat(12)0.36%
Revenue beat(16)11
Avg Revenue beat(16)2.75%
PT rev (1m)13.16%
PT rev (3m)10.75%
EPS NQ rev (1m)-1.05%
EPS NQ rev (3m)0.66%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)0.77%
Revenue NQ rev (1m)1.32%
Revenue NQ rev (3m)1.28%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.38 | ||
| Fwd PE | 23.08 | ||
| P/S | 4.91 | ||
| P/FCF | 35.14 | ||
| P/OCF | 28.06 | ||
| P/B | 4.21 | ||
| P/tB | N/A | ||
| EV/EBITDA | 22.62 |
EPS(TTM)19.49
EY3.94%
EPS(NY)21.44
Fwd EY4.33%
FCF(TTM)14.08
FCFY2.85%
OCF(TTM)17.63
OCFY3.56%
SpS100.79
BVpS117.59
TBVpS-33.43
PEG (NY)6.39
PEG (5Y)2.1
Graham Number227.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.38% | ||
| ROE | 12.88% | ||
| ROCE | 9.13% | ||
| ROIC | 6.43% | ||
| ROICexc | 6.7% | ||
| ROICexgc | 29.73% | ||
| OM | 18.4% | ||
| PM (TTM) | 15.02% | ||
| GM | 41.43% | ||
| FCFM | 13.97% |
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.8%
ROE(5y)15.76%
ROIC(3y)6.66%
ROIC(5y)7.62%
ROICexc(3y)7.33%
ROICexc(5y)8.51%
ROICexgc(3y)36.42%
ROICexgc(5y)41.56%
ROCE(3y)9.48%
ROCE(5y)10.9%
ROICexgc growth 3Y-8.22%
ROICexgc growth 5Y1.35%
ROICexc growth 3Y-8.88%
ROICexc growth 5Y2.89%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-6.24%
GM growth 5Y-1.42%
F-Score8
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 5.84 | ||
| Debt/EBITDA | 2.94 | ||
| Cap/Depr | 55.1% | ||
| Cap/Sales | 3.52% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 70.55% | ||
| Profit Quality | 93% | ||
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.11 | ||
| Altman-Z | N/A |
F-Score8
WACC10.18%
ROIC/WACC0.63
Cap/Depr(3y)51.6%
Cap/Depr(5y)63.11%
Cap/Sales(3y)3.9%
Cap/Sales(5y)4.54%
Profit Quality(3y)109.9%
Profit Quality(5y)104.9%
High Growth Momentum
Growth
EPS 1Y (TTM)4.53%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%9.66%
EPS Next Y3.97%
EPS Next 2Y6.16%
EPS Next 3Y7.56%
EPS Next 5Y9.78%
Revenue 1Y (TTM)3.22%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%4.94%
Revenue Next Year2.82%
Revenue Next 2Y3.82%
Revenue Next 3Y4.52%
Revenue Next 5Y4.62%
EBIT growth 1Y8.68%
EBIT growth 3Y-9.38%
EBIT growth 5Y12.7%
EBIT Next Year13.53%
EBIT Next 3Y9.14%
EBIT Next 5Y8.68%
FCF growth 1Y-6.66%
FCF growth 3Y2.29%
FCF growth 5Y12.42%
OCF growth 1Y-6.36%
OCF growth 3Y-2.36%
OCF growth 5Y11.75%
THERMO FISHER SCIENTIFIC INC / TN8.DE FAQ
What is the fundamental rating for TN8 stock?
ChartMill assigns a fundamental rating of 4 / 10 to TN8.DE.
What is the valuation status of THERMO FISHER SCIENTIFIC INC (TN8.DE) stock?
ChartMill assigns a valuation rating of 2 / 10 to THERMO FISHER SCIENTIFIC INC (TN8.DE). This can be considered as Overvalued.
What is the profitability of TN8 stock?
THERMO FISHER SCIENTIFIC INC (TN8.DE) has a profitability rating of 6 / 10.
What are the PE and PB ratios of THERMO FISHER SCIENTIFIC INC (TN8.DE) stock?
The Price/Earnings (PE) ratio for THERMO FISHER SCIENTIFIC INC (TN8.DE) is 25.38 and the Price/Book (PB) ratio is 4.21.
How sustainable is the dividend of THERMO FISHER SCIENTIFIC INC (TN8.DE) stock?
The dividend rating of THERMO FISHER SCIENTIFIC INC (TN8.DE) is 3 / 10 and the dividend payout ratio is 9.48%.